Researchers have developed a new methodology that uses artificial intelligence tools to identify and count target viruses ...
The viral vector and plasmid DNA manufacturing market offers growth opportunities in gene therapies, contract manufacturing, and emerging markets like Asia-Pacific. Key trends include rising demand ...
New expedited service line designed for biotechs with timeline constraints, launched in response to client demandCan accelerate timeline to GMP ...
Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing and quality control services. SHIRLEY, NY, UNITED ...
Researchers at North Carolina State University have developed an AI-enhanced electrochemical sensing method to quickly and accurately quantify viral vectors used in gene therapies. The approach uses ...
Researchers developed a gorilla adenovirus platform with inherent tumor selectivity, lung tropism, and large-gene capacity.
SYDNEY, March 18, 2026 (GLOBE NEWSWIRE) -- Viral Vector Manufacturing Facility Pty Ltd (VVMF), Australia’s first commercial viral vector Contract Development and Manufacturing Organisation (CDMO), ...
Detailed price information for Oxford Biomedica Plc New (OXBDF) from The Globe and Mail including charting and trades.
Global health agencies are intensifying surveillance and preparedness efforts against emerging infectious diseases, from dengue and malaria to novel viral threats. The WHO has released new R&D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results